1. Home
  2. EEFT vs BBIO Comparison

EEFT vs BBIO Comparison

Compare EEFT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euronet Worldwide Inc.

EEFT

Euronet Worldwide Inc.

HOLD

Current Price

$78.20

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$76.38

Market Cap

14.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEFT
BBIO
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
14.7B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
EEFT
BBIO
Price
$78.20
$76.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
21
Target Price
$117.60
$76.24
AVG Volume (30 Days)
854.9K
2.0M
Earning Date
02-12-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
6.78
N/A
Revenue
$4,182,800,000.00
$353,780,000.00
Revenue This Year
$9.05
$128.44
Revenue Next Year
$7.63
$76.14
P/E Ratio
$11.56
N/A
Revenue Growth
7.25
62.46
52 Week Low
$68.56
$26.55
52 Week High
$114.25
$78.44

Technical Indicators

Market Signals
Indicator
EEFT
BBIO
Relative Strength Index (RSI) 60.74 64.64
Support Level $76.18 $73.48
Resistance Level $79.28 $78.44
Average True Range (ATR) 2.03 2.36
MACD 0.48 -0.18
Stochastic Oscillator 85.25 72.81

Price Performance

Historical Comparison
EEFT
BBIO

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: